| # | Drug Name | Docking Score | Protein Type | Drug From | CAS |
|---|---|---|---|---|---|
| 1 | Temsirolimus | -22.80 | TYK2 | NHI | 162635-04-3 |
| 2 | Trabectedin | -22.30 | TYK2 | FDA | 114899-77-3 |
| 3 | Oritavancin | -19.80 | FMO5 | FDA NHI | 171099-57-3 |
| 4 | N-[(E)-1-[(2S,4S)-4-[(2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]benzamide | -19.70 | DPP9 | FDA NHI | |
| 5 | Irinotecan | -19.50 | TYK2 | FDA | 97682-44-5 |
| 6 | N-[(E)-1-[(2S,4S)-4-[(2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]benzamide | -19.20 | TYK2 | FDA NHI | |
| 7 | Midostaurin | -19.10 | TYK2 | FDA NHI | 120685-11-2 |
| 8 | Oritavancin | -19.10 | TYK2 | FDA NHI | 171099-57-3 |
| 9 | Oritavancin | -19.00 | ASIC2 | FDA NHI | 171099-57-3 |
| 10 | Idarubicin | -18.70 | DPP9 | FDA | 58957-92-9 |